-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$7.00213.9% Upside
Harvard Bioscience, Inc. Frequently Asked Questions
-
What analysts cover Harvard Bioscience, Inc.?
Harvard Bioscience, Inc. has been rated by research analysts at KeyBanc in the past 90 days.